Blackstone Agrees to Buy Takeda Japan Healthcare Unit

Woman taking medicine

Blackstone, one of the leading investment firms in the world, announced that it will acquire Takeda Consumer Healthcare Company Limited (TCHC), a subsidiary of Takeda Pharmaceutical Company Ltd.

The transaction is around $2.3 billion, however Takeda says the price could alter according to net debt and working capital. Blackstone expects the deal to close by 31 March, 2021.

Atsuhiko Sakamoto, Head of Private Equity in Blackstone Japan said, “We are privileged to announce this partnership and invest in the company’s plans to become the leading consumer healthcare business in Japan. TCHC is well-positioned to grow its established brands in Japan and launch new and expanded product offerings. We see tremendous potential for TCHC in Japan and throughout Asia, and we are confident th...

Login In

or

Register now for free access

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments